Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Introduction to Market Drivers and Restraints
4.3 Market Drivers
4.3.1 Rising Demand for 3D Imaging in Diagnosing and Monitoring of Chronic Diseases
4.3.2 Rising Healthcare Expenditures
4.3.3 Development of Modern Visualization Methods and Technology Platforms
4.4 Market Restraints
4.4.1 High Initial Costs of Equipment
4.5 Industry Value Chain Analysis
4.6 Industry Attractiveness - Porter’s Five Force Analysis
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers/Consumers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitute Products
4.6.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Deployment
5.1.1 On-premise
5.1.2 Cloud
5.2 By Component
5.2.1 Hardware
5.2.2 Software & Solution
5.3 By Application
5.3.1 CT-Scan
5.3.2 MRI
5.3.3 Ultrasound
5.3.4 Neurological Imaging
5.3.5 Spinal Imaging
5.3.6 Other Applications
5.4 Geography
5.4.1 North America
5.4.2 Europe
5.4.3 Asia-Pacific
5.4.4 Latin America
5.4.5 Middle East & Africa


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Ambra Health Inc.
6.1.2 Arterys Inc.
6.1.3 Brainlab AG
6.1.4 Depuy Synthes Inc.
6.1.5 Kitware Inc.
6.1.6 Medtronic Inc.
6.1.7 Mach7 Technologies Ltd.
6.1.8 NDS Surgical Imaging LLC
6.1.9 Olympus Corporation
6.1.10 NerveVision Inc.
6.1.11 Siemens Healthcare Pvt. Ltd.
6.1.12 Pie Medical Imaging BV
6.1.13 Quibim SI


7 INVESTMENT ANALYSIS


8 MARKET OPPORTUNITIES AND FUTURE OUTLOOK